UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery

Circulation (New York, N.Y.), 1998-08, Vol.98 (5), p.429-434

1998

Volltextzugriff (PDF)

Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII

The Journal of thoracic and cardiovascular surgery, 2002-10, Vol.124 (4), p.852-854

2002

Volltextzugriff (PDF)

Data envelopment analysis with imprecise data

European journal of operational research, 2002-07, Vol.140 (1), p.24-36

2002

Volltextzugriff (PDF)

P‐TA‐3 | Characterization of Spirometric Response to Therapeutic Plasma Exchange (TPE) and Factors Associated with Respiratory Distress in Myasthenia Gravis Patients

Transfusion (Philadelphia, Pa.), 2023-10, Vol.63 (S5), p.245A-246A

2023

Volltextzugriff (PDF)

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass

The Journal of thoracic and cardiovascular surgery, 2005-07, Vol.130 (1), p.107-113

2005

Volltextzugriff (PDF)

Assessing the cost-effectiveness of university academic recruitment and promotion policies

European journal of operational research, 2018-01, Vol.264 (2), p.742-755

2018

Volltextzugriff (PDF)

A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

Anesthesiology (Philadelphia), 2005-02, Vol.102 (2), p.276-284

2005

Volltextzugriff (PDF)

Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients

Anesthesia and analgesia, 1996-01, Vol.82 (1), p.13-21

1996

Volltextzugriff (PDF)

The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation

The Journal of thoracic and cardiovascular surgery, 1995-07, Vol.110 (1), p.46-54

1995

Volltextzugriff (PDF)

Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation

The Journal of thoracic and cardiovascular surgery, 1994-01, Vol.107 (1), p.271-279

1994

Volltextzugriff (PDF)

Antithrombin III During Cardiac Surgery: Effect on Response of Activated Clotting Time to Heparin and Relationship to Markers of Hemostatic Activation

Anesthesia and analgesia, 1997-09, Vol.85 (3), p.498-506

1997

Volltextzugriff (PDF)

The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)

The Annals of thoracic surgery, 2005-04, Vol.79 (4), p.1454-1461

2005

Volltextzugriff (PDF)

Uses of antithrombin III concentrate in congenital and acquired deficiency states

Transfusion (Philadelphia, Pa.), 1998-05, Vol.38 (5), p.481-498

1998

Volltextzugriff (PDF)

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations

The Journal of thoracic and cardiovascular surgery, 1994-12, Vol.108 (6), p.1076-1082

1994

Volltextzugriff (PDF)

Off-Label Use of Recombinant Factor VIIA Concentrates After Cardiac Surgery

The Annals of thoracic surgery, 2005-07, Vol.80 (1), p.3-5

2005

Volltextzugriff (PDF)

Recombinant human transgenic Antithrombin in cardiac surgery: A dose-finding study

Anesthesiology (Philadelphia), 2002-05, Vol.96 (5), p.1095-1102

2002

Volltextzugriff (PDF)

More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT

Thrombosis and haemostasis, 1996, Vol.76 (6), p.902-908

1996

Volltextzugriff (PDF)

A Patient with Prolonged Paralysis/Commentary/Commentary

Clinical chemistry (Baltimore, Md.), 2012-03, Vol.58 (3), p.496

2012

Volltextzugriff (PDF)

Adverse Events in Platelet Apheresis Donors: A Multivariate Analysis in a Hospital–Based Program

Vox sanguinis, 1999-01, Vol.77 (1), p.24-32

1999

Volltextzugriff (PDF)

Warfarin therapy does not increase bleeding in patients undergoing heart transplantation

The Annals of thoracic surgery, 2001-09, Vol.72 (3), p.714-718

2001

Volltextzugriff (PDF)

On-site prothrombin time, activated partial thromboplastin time, and platelet count : a comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery

Anesthesiology (Philadelphia), 1994-02, Vol.80 (2), p.338-351

1994

Volltextzugriff (PDF)

Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting

The Annals of thoracic surgery, 1999-02, Vol.67 (2), p.417-422

1999

Volltextzugriff (PDF)

Response of kaolin ACT to heparin: Evaluation with an automated assay and higher heparin doses

The Annals of thoracic surgery, 1996-03, Vol.61 (3), p.795-799

1996

Volltextzugriff (PDF)

Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor

Critical care medicine, 1995-10, Vol.23 (10), p.1674-1679

1995

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Science & Technology
(33)
Life Sciences & Biomedicine
(30)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Cardiovascular System & Cardiology
(16)
Cardiac & Cardiovascular Systems
(15)
Male
(14)
Middle Aged
(14)
Respiratory System
(14)
Female
(13)
Surgery
(13)
Aged
(11)
Anesthesiology
(10)
Pharmacology. Drug Treatments
(10)
Blood. Blood Coagulation. Reticuloendothelial System
(9)
Cardiopulmonary Bypass
(9)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(9)
Adult
(8)
Prospective Studies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery

Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

Data envelopment analysis with imprecise data

P‐TA‐3 | Characterization of Spirometric Response to Therapeutic Plasma Exchange (TPE) and Factors Associated with Respiratory Distress in Myasthenia Gravis Patients

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass

Assessing the cost-effectiveness of university academic recruitment and promotion policies

A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients

The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation

Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation

Antithrombin III During Cardiac Surgery: Effect on Response of Activated Clotting Time to Heparin and Relationship to Markers of Hemostatic Activation

The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)

Uses of antithrombin III concentrate in congenital and acquired deficiency states

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations

Off-Label Use of Recombinant Factor VIIA Concentrates After Cardiac Surgery

Recombinant human transgenic Antithrombin in cardiac surgery: A dose-finding study

More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT

A Patient with Prolonged Paralysis/Commentary/Commentary

Adverse Events in Platelet Apheresis Donors: A Multivariate Analysis in a Hospital–Based Program

Warfarin therapy does not increase bleeding in patients undergoing heart transplantation

On-site prothrombin time, activated partial thromboplastin time, and platelet count : a comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery

Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting

Response of kaolin ACT to heparin: Evaluation with an automated assay and higher heparin doses

Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor

Suchergebnisse filtern